CE vs TMDX · rev $5.09B vs P/E 17, rev $363.9M
Celanese Corporation (CE) versus TransMedics Group Inc (TMDX) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
Latest reported CE revenue for 2026-06-30 was $5.09B. Net income was $169.0M. CE currently screens at market cap $5.92B.
Latest reported TMDX revenue for 2026-06-30 was $363.9M. Net income was $22.0M. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
CE currently screens at market cap $5.92B. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
Not investment advice. Open the CE and TMDX stock pages for the full models.
Not investment advice.